BioCentury
ARTICLE | Financial News

Intellia, Assembly price follow-ons

November 2, 2017 8:43 PM UTC

Intellia Therapeutics Inc. (NASDAQ:NTLA) and Assembly Biosciences Inc. (NASDAQ:ASMB) each priced follow-ons, raising more than $210 million.

Intellia raised $150 million late Wednesday through the sale of 6.3 million shares at $24 in a follow-on underwritten by Credit Suisse, Jefferies and Leerink. The price is a 23% discount to Intellia’s close of $31.12 on Tuesday, the day before the offering was announced. Intellia lost $4.47 (18%) to $21 on Thursday...